Protein oxidation in the brain in Alzheimer's disease

Neuroscience

Volumn 103, Issue 2, 2001, Pages 373-383

  Aksenov, M Y ^a,c   Aksenova, M V ^a,b   Butterfield, D A ^a,b   Geddes, J W ^a,c   Markesbery, W R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

2D electrophoresis; 2D western blotting; Alzheimer's disease; Immunohistochemistry; Protein carbonyls; Protein oxidation

Indexed keywords

ANTIBODY; BETA ACTIN; BETA TUBULIN; CARBONYL DERIVATIVE; CREATINE KINASE BB; GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL DEGENERATION; OXIDATION; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; SUBICULUM; TEMPORAL LOBE;

ACTINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; BRAIN; CEREBELLUM; CREATINE KINASE; CREATINE KINASE, BB FORM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISOENZYMES; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PARAHIPPOCAMPAL GYRUS; TAU PROTEINS; TUBULIN;

EID: 0035857738     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00580-7     Document Type: Article

References (52)

1. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders
2. Aging in a dish: Age-dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long-term hippocampal cell culture
3. Glutamine synthetase-induced enhancement of β-amyloid peptide Aβ(1-40) accompanied by abrogation of fibril formation and Aβ fragmentation
4. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease
5. Oxidative modification of creatine kinase BB in Alzheimer's disease brain
6. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
7. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
8. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins)
9. Protein oxidation processes in aging brain
10. Biochemistry and pathology of radical-mediated protein oxidation
11. Age-related losses of cognitive function and motor skills in mice associated with oxidative protein damage in the brain
12. Immunocytochemical studies of actin localization in the central nervous system
13. Carbonylated proteins in aging and exercise: Immunoblot approaches
14. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
15. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide
16. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons
17. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
18. Redox regulation of cellular signalling
19. An immunochemical study on tau glycation in paired helical filaments
20. Epitopes that span the tau molecule are shared with paired helical filaments
21. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
22. 3-Nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: Insights into Huntington's disease
23. Diffusible, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins
24. Analysis of microtubule-associated protein tau glycation in paired helical filaments
25. Carbonyl assays for determination of oxidatively modified proteins
26. Amyloid beta-peptide and oxidative injury in Alzheimer's disease
27. Oxidative stress hypothesis in Alzheimer's disease
28. Oxidative alterations in Alzheimer's disease
29. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
30. Soluble pool of Aβ-amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
31. Prolonged oxidative stress on actin
32. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: Standardization of the neuropathologic assessment of Alzheimer's disease
33. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis
34. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
35. Clusterin (apoJ) alters the aggregation of amyloid-β-peptide (Aβ 1-42) and forms slowly sedimenting Aβ-complexes that cause oxidative stress
36. Ultrastructural localization of actin in the cell body of rat spinal ganglion neurons
37. Free radicals in Alzheimer's disease
38. Low levels of reactive oxygen species as modulators of cell function
39. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
40. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease
41. Protein oxidation in aging brain
42. Widespread peroxynitrite-mediated damage in Alzheimer's disease
43. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine
44. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
45. Metal ion-catalyzed oxidation of proteins: Biochemical mechanisms and biological consequences
46. Is amyloid beta-protein glycated in Alzheimer's disease?
47. A double stain for total and oxidized proteins from two-dimensional fingerprints
48. In vitro polymerization of oxidized tau into filaments
49. Acetaldehyde and microtubules
50. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
51. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
52. Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro